https://graniterecord.org/bill/2026/sb256.html (New Title) establishing safety and care requirements for clinician-administered drugs. en-us Fri, 04 Sep 2026 00:00:00 +0000 https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-09-09:subcommittee-work-session-09-09-2026-10-Wed, 09 Sep 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Subcommittee Work Session: 09/09/2026 10:00 am GP 229 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-05-14:refer-for-interim-study-ma-vv-05-14-2026Thu, 14 May 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Refer for Interim Study: MA VV 05/14/2026 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-05-01:committee-report-refer-for-interim-studyFri, 01 May 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-04-29:executive-session-04-29-2026-10-00-am-gpWed, 29 Apr 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Executive Session: 04/29/2026 10:00 am GP 229 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-04-22:subcommittee-work-session-04-22-2026-10-Wed, 22 Apr 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Subcommittee Work Session: 04/22/2026 10:00 am GP 229 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-04-08:subcommittee-work-session-04-08-2026-10-Wed, 08 Apr 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Subcommittee Work Session: 04/08/2026 10:00 am GP 229 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-04-07:public-hearing-04-07-2026-02-15-pm-gp-15Tue, 07 Apr 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Public Hearing: 04/07/2026 02:15 pm GP 159 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-03-02:vacated-and-referred-to-commerce-and-conMon, 02 Mar 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-02-19:introduced-in-recess-of-02-19-2026-and-rThu, 19 Feb 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-01-07:committee-amendment-2025-3029s-aa-vv-01-Wed, 07 Jan 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Committee Amendment # 2025-3029s, AA, VV; 01/07/2026 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2026-01-07:ought-to-pass-with-amendment-2025-3029s-Wed, 07 Jan 2026 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2025-10-22:committee-report-ought-to-pass-with-amenWed, 22 Oct 2025 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2025-03-06:committee-report-rereferred-to-committeeThu, 06 Mar 2025 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2025-03-06:rereferred-to-committee-ma-vv-03-06-2025Thu, 06 Mar 2025 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Rereferred to Committee, MA, VV; 03/06/2025 Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2025-02-12:hearing-02-12-2025-room-101-lob-09-15-amWed, 12 Feb 2025 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Hearing: 02/12/2025, Room 101, LOB, 09:15 am Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT https://graniterecord.org/bill/2026/sb256.htmlSB256:2025-01-09:introduced-01-09-2025-and-referred-to-heThu, 09 Jan 2025 00:00:00 +0000(New Title) establishing safety and care requirements for clinician-administered drugs. Introduced 01/09/2025 and Referred to Health and Human Services Status: House: INTERIM STUDY · Senate: PASSED/ADOPTED WITH AMENDMENT